Table 2.

Changes in the nutritional outcome and prognosis

	Baseline	After 12 weeks	Change from baseline to post treatment measurements	MD	95% CI	Effect size (d)
Main measurement of nutritional outcome
Body Weight (kg)
PAG (n 32)	56.8 [13.8]	56.3 [13.0]	−0.5 [1.4]	3.00	2.00, 4.00	2.87
RAG (n 30)	55.5 [10.4]	58.0 [10.8]	2.5 [0.4]
%IBW: ideal body weight (%)
PAG (n 32)	96.7 [17.7]	95.9 [16.5]	−0.8 [2.4]	5.20	3.52, 7.00	1.51
RAG (n 30)	98.6 [17.7]	103.0 [18.3]	4.4 [4.3]
Prognosis outcome measurement
BODE index
PAG (n 32)	3.3 [2.4]	3.3 [2.4]	−0.03[1.0]	−1.17	−1.55, − 0.55	1.06
RAG (n 30)	3.9 [2.4]	2.7 [1.7]	−1.2 [1.2]
BMI
PAG (n 32)	0.5 [0.5]	0.4 [0.5]	−0.1 [1.3]	−0.11
RAG (n 30)	0.4 [0.5]	0.2 [0.4]	−0.2 [0.5]
%FEV1
PAG (n 32)	1.5 [1.1]	1.7 [1.1]	0.2 [0.4]	−0.29
RAG (n 30)	1.8 [1.0]	1.6 [1.0]	−0.1 [0.6]
mMRC
PAG (n 32)	0.9 [1.1]	0.8 [1.1]	−0.1[0.5]	−0.51
RAG (n 30)	1.2 [1.0]	0.6 [0.8]	−0.6 [0.7]
6MWD
PAG (n 32)	0.4 [0.7]	0.4 [0.7]	0.0 [0.3]	−0.30
RAG (n 30)	0.5 [0.9]	0.3 [0.5]	−0.3 [0.7]

MD mean difference, %IBW ideal body weight (%), BODE index BMI (B); degree of air flow obstruction (O); functional dyspnea (D); and exercise capacity (E), assessed by the 6MWD. BMI body mass index, %FEV₁ % forced expiratory volume in 1 s, mMRC Modified Medical Research Council, 6MWD 6 minute walk distance